Covid-19 Respiratory Sequelae French Cohort

CompletedOBSERVATIONAL
Enrollment

2,933

Participants

Timeline

Start Date

October 7, 2021

Primary Completion Date

April 1, 2023

Study Completion Date

May 1, 2024

Conditions
COVID-19FibrosisCohortFollow-upSequelaeSpirometry DLCO
Trial Locations (1)

80054

CHU Amiens Picardie, Amiens

All Listed Sponsors
collaborator

Cabinet Medical valenciennes

UNKNOWN

collaborator

CH Aix

UNKNOWN

collaborator

hopital privé de bois bernard

UNKNOWN

collaborator

Clinique La Croix du Sud

UNKNOWN

collaborator

University Hospital, Bordeaux

OTHER

collaborator

Hopital Forcilles

OTHER

collaborator

Hopital d'instructions des armées

UNKNOWN

collaborator

Hôpital Européen Marseille

OTHER

collaborator

Rennes University Hospital

OTHER

collaborator

Clinique Saint Augustin

UNKNOWN

collaborator

Delafontaine Hospital

OTHER

collaborator

Centre Hospitalier Universitaire de Saint Etienne

OTHER

collaborator

Centre Hospitalier de Troyes

OTHER

collaborator

Centre Hospitalier le Mans

OTHER

collaborator

University Hospital, Clermont-Ferrand

OTHER

collaborator

University Hospital, Tours

OTHER

lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT05075785 - Covid-19 Respiratory Sequelae French Cohort | Biotech Hunter | Biotech Hunter